Life Sciences organizations need to bring new high-quality  therapeutics to market fast to respond to patient needs specific to different diseases and geographies. But development time and costs for new therapeutics are gigantic, with  an average accrual of $2.6B and 12 years from ideation to market. With long product  development times, Life Sciences  organizations must accelerate the pace and quality of innovation for long-term success.

To collaborate more efficiently and productively, organizations are moving from paper lab notebooks and legacy  systems that can be tedious to implement and update, to flexible ELNs that are cost-effective, easy to deploy and adopt across disciplines and global sites.

Download the white paper to learn about digital documentation as part of a fully integrated scientific enterprise, courtesy of BIOVIA, Dassault Systèmes.